Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy

Journal of Neurology

Volumn 245, Issue 10, 1998, Pages 681-685

  Chan, Andrew ^a   Reichmann, Heinz ^a,b   Kögel, Anke ^a   Beck, Andreas ^a   Gold, Ralf ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Bicycle ergometry; Coenzyme Q10; Lactate; Lactate pyruvate ratio; Mitochondrial encephalomyopathies

Indexed keywords

LACTIC ACID; PYRUVIC ACID; UBIDECARENONE;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; ENCEPHALOMYOPATHY; FEMALE; HUMAN; MALE; MITOCHONDRIAL MYOPATHY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TIME; TREATMENT OUTCOME; WORKLOAD;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; SENSITIVITY AND SPECIFICITY; UBIQUINONE;

EID: 0031757804     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050267     Document Type: Article

References (18)

1. Bendahan D, Desnuelle C, Vanuxem D, et al (1992) 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42: 1203-1208
2. Bresolin N, Doriguzzi C, Ponzetto C, et al (1990) Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 10: 70-78
3. Chan A, Gold R, Arp S, Pflughaupt KW, Toyka KV, Reichmann H (1998) Standardisierter Fahrradergometertest bei mitochondrialen Myopathien: Indikation, Störfaktoren und klinisch aussagekräftige Parameter. Nervenarzt (in press)
4. Chen RS, Huang CC, Lee CC, et al (1993) Overlapping syndrome of MERRF and MELAS: molecular and neuroradiological studies. Acta Neurol Scand 87: 494-498
5. Clark KM, Bindoff LA, Lightowlers RN, et al (1997) Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet 16: 222-224
6. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL (1995) Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45: 1193-1198
7. Fadic R, Johns DR (1996) Clinical spectrum of mitochondrial diseases. Semin Neurol 16: 11-20
8. Gold R, Seibel P, Reinelt G, et al (1996) Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q. Eur Neurol 36: 191-196
9. Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 118: 339-357
10. Mashima Y, Hüda Y, Oguchi Y (1992) Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 340 : 368-369
11. Matthews PM, Ford B, Dandurand RJ, et al (1993) Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 43: 884-890
12. Nishikawa Y, Takahashi M, Yorifuji S, et al (1989) Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study. Neurology 39: 399-403
13. Ogasahara S, Nishikawa Y, Yorifuji S, et al (1986) Treatment of Kearns-Sayre syndrome with coenzyme QlO. Neurology 36: 45-53
14. Piccolo G, Banfi P, Azan G, et al (1991) Biologic markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia. J Neurol Sci 105: 57-60
15. Sobreira C, Hirano M, Shanske S, et al (1997) Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48: 1238-1243
16. Taivassalo T, Matthews PM, De Stefano N, et al (1996) Combined aerobic-training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology 47: 529-533
17. Zierz S, Jahns G, Jerusalem F (1989) Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 236: 97-101
18. Zierz S, Meeben S, Jerusalem F (1989) Lactat- and Pyruvatblutspiegel in der Diagnostik mitochondrialer Myopathien. Nervenarzt 60: 545-548